Methods to Detect Antifibrillarin Antibodies in Patients with Systemic Sclerosis (SSc): A Comparison

Journal of Clinical Laboratory Analysis

Volumn 18, Issue 1, 2004, Pages 19-26

  García, Josefina Huerta ^a   Osuna, Monica Delgado ^a   Castrejon, Filiberto Martinez ^a   Enriquez, Laura Guzman ^a   Reyes, Pedro A ^b   Cortes Hermosillo, J Jesus ^a,c  

^a UNIVERSIDAD AUTÓNOMA DE ZACATECAS   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^c NONE   (Mexico)

Author keywords

Immunofluorescence; Immunoprecipitation snoRNAs; Rheumatic diseases; Western blot

Indexed keywords

AUTOANTIBODY; CENTROMERE ANTIBODY; FIBRILLARIN; FIBRILLARIN ANTIBODY; RIBONUCLEOPROTEIN; RNA POLYMERASE II; SMALL NUCLEAR RNA; SMALL NUCLEOLAR RNA; UNCLASSIFIED DRUG;

ADULT; ANALYTIC METHOD; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MALE; RHEUMATIC DISEASE; SCLERODERMA; SPLICEOSOME; SYSTEMIC SCLEROSIS; WESTERN BLOTTING;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; BLOTTING, WESTERN; CHROMOSOMAL PROTEINS, NON-HISTONE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HELA CELLS; HUMANS; IMMUNOLOGIC TESTS; PRECIPITIN TESTS; RNA, SMALL NUCLEOLAR; SCLERODERMA, SYSTEMIC;

EID: 0842304141     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcla.20003     Document Type: Article

References (46)

1. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases as probes for cell biology. Adv Immunol 1989;44:93-151.
2. Tan EM, Rodnan GP, Garcia I, Moroi Y, Fritzler MJ, Peebles C. Diversity of antinuclear antibodies in progressive systemic sclerosis: anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum 1980;23:617-625.
3. Pollard KM, Reimer G, Tan EM. Autoantibodies in scleroderma. Clin Exp Rheumatol 1989;7:S57-S62.
4. Kipnis RJ, Craft J, Hardin JA. The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays. Arthritis Rheum 1990;33:1431-1437.
5. Fritzler MJ. Autoantibodies in scleroderma. J Dermatol 1993;20:257-268.
6. Vazquez Abad D, Rothfield NF. Autoantibodies in systemic sclerosis. Intern Rev Immunol 1995;12:145-157.
7. Chang M, Wang RJ, Yangco DT, Sharp GC, Komatireddy GR, Hoffman RW. Analysis of autoantibodies against RNA polymerases using immunoaffinity purified RNA polymerase I, II and III antigen in an enyme-linked immunosorbent assay. Clin Immunol Immunopathol 1998;89:71-78.
8. Harvey GR, Butts S, Rands AL, Patel Y, McHugh NJ. 1999. Clinical and serological associations with anti-RNA polymerases antibodies in systemic sclerosis. Clin Exp Immunol 117:395-402.
9. Yu Y, Scharl EC, Smith CM, Steitz JA. 1999. The growing world of small nuclear ribonucleoprotein. In: Gesteland RF, Cech TR, Atkins JF, editors. The RNA world. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. p 487-524.
10. Nilsen TW. RNA-RNA interactions in the spliceosome: unraveling the ties that bind. Cell 1994;78:1-4.
11. Smith C, Steitz JA. Sno storm in the nucleolus: new roles for myriad small RNPs. Cell 1997;89:669-672.
12. Fatica A, Gallardi S, Altieri F, Bozzoni I. Fibrillarin binds directly and specifically to U16 C/D snoRNA. RNA 2000;6:88-95.
13. Ni J, Fournier MJ. 1997. Small nucleolar RNAs direct site-specific synthesis of pseurouridine in ribosomal RNA. Cell 1997;89:565-573.
14. Ganot P, Bortolin ML, Kiss T. Site specific pseudouridine formation in preribosomal RNA is guided by small nucleolar RNAs. Cell 1997;89:799-809.
15. Yang Y, Isaac C, Wang C, Dragon F, Pogai V, Meier T. Conserved composition of mammalian box H/ACA and Box C/D small nucleolar ribonucleoprotein particles and their interaction with the common factor Nopp140. Mol Biol Cell 2000;11:567-577.
16. Thiry M. Ultrastructural detection of DNA within the nucleolus by sensitive molecular immunocytochemistry. Exp Cell Res 1992;20:135-144.
17. Thiry M. New data concerning the functional organization of the mammalian cell mucleolus: detection of RNA and rRNA by in situ molecular imunocytochemistry. Nucl Acid Res 1992;20:6195-6200.
18. Aris JP, Blobel G. cDNA cloning and sequencing of human fibrillarin, a conserved nucleolar protein recognized by autoimmune antisera. Proc Natl Acad Sci U S A 1991;88:931-935.
19. Jensen RP, Hurt EC, Kern H, et al. Evolutionary conservation of the human nucleolar protein fibrillarin and its functional expression in yeast. J Cell Biol 1991;113:715-729.
20. Tyc K, Steitz JA. U3, U8, and U13 comprise a new class of mammalin snRNPs localized to the cell nucleolus. EMBO J 1989;8:3113-3119.
21. Baserga SJ, Yang X, Steitz JA. An intact box C sequence in the U3 snoRNA is required for binding of fibrillarin, the protein common to the major family of nucleolar snRNPs. EMBO J 1991;10:2645-2651.
22. Peculis B, Steitz JA. Sequence and structural elements critical for U8 snRNP function in Xenopus oocytes are evolutionary conserved. Genes Dev 1994;8:2241-2255.
23. Tycowski KT, Shu MD, Steitz JA. Requirement for intron-encoded U22 small nucleolar RNA in 18S ribosomal RNA maturation. Science 1994;266:1558-1561.
24. Tycowski K, Shu MD, Steitz JA. A mammalian gene whose introns instead of exons generate stable RNA products. Nature 1996;379:464-466.
25. Tycowski K, Smith C, Shu MD, Steitz JA. A small nucleolar RNA requirement for site specific ribose methylation of rRNA in Xenopus. Proc Natl Acad Sci U S A 1996;93:14480-14485.
26. Caffarelli E, Fatica A, Prislei S, De Gregorio E, Fragapane P, Bozzoni I. Processing of the intron-encoded U16 and U18 snoRNAs: the conserved C and D boxes control both the processing reaction and the stability of the mature snoRNA. EMBO J 1996;15:1121-1131.
27. Balakin AG, Smith M, Fournier J. The RNA world of the nucleolus: two major families of small RNAs defined by different box elements related functions. Cell 1996;86:823-834.
28. Nicoloso M, Qu LH, Michot B, Bachellerie JP. Intron-encoded, antisense small nucleolar RNAs: the characterization of nine novel species points to their direct role as guides for the 2′-O-ribose methylation of rRNAs. J Mol Biol 1996;260:178-195.
29. Ochs RL, Lischwe MA, Spohn WH, Busch H. Fibrillarin: a new protein of the nucleolus identified by autoimmune sera. Biol Cell 1985;54:123-134.
30. Lischwe MA, Ochs RL, Reddy R, et al. Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34.000; pI, 8.5) rich in NGdimethylarginine. J Biol Chem 1985;260:14304-14310.
31. LeRoy EC, Black CM, Fleischmajer R, Jablonska S. Scleroderma (systemic sclerosis), classification, subsets and pathogenesis. J Rheumatol 1988;15:202-205.
32. Matera AG, Ward DC. Nucleoplasmic organization of small nuclear ribonucleoproteins in cultured human cells. J Cell Biol 1993;121:715-727.
33. Fritzler MJ. Fluorescent antinuclear antibody test. In: Rose NR, Friedman H, editors. Manual of clinical immunology. Washington, DC: American Society for Microbiology; 1980. p 852.
34. Matera AG, Frey MR, Margelot K, Wolin SL. A perinucleolar compartment contains several RNA polymerase III transcripts as well as the polypyrimidine tract-binding protein, hnRNP I. J Cell Biol 1995;129:1181-1193.
35. Steitz JA. Immunoprecipitation of ribonucleoproteins using autoantibodies. Methods Enzymol 1989;180:468-481.
36. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
37. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and applications. Proc Natl Acad Sci U S A 1979;76:4350-4354.
38. England TE, Bruce AG, Uhlenbeck OC. Specific labelling of 3′ end termini of RNA with T4 RNA ligase. Methods Enzymol 1980;65:65-74.
39. Chaconas G, Van de Sande JH. 5′32P labelling of RNA and DNA fragments. Methods Enzymol 1980;65:75-88.
40. Fritzler MJ. Autoantibodies: diagnostic fingerprints and etiologic perplexities. Clin Invest Med 1997;20:50-66.
41. Evans J. Antinuclear antibody testing in systemic autoimmune disease. Clin Chest Med 1998;19:613-625.
42. Bauerfeind S, Heide KG. Determination of autoimmune antibodies using Western blot technique in the routine laboratory. Problems with determining and comparing three test kits. Z Rheumatol 1994;53:66-71.
43. Tan EM, Smolen JS, McDougal JS, et al. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum 1999;42:455-464.
44. Villalta D, Bizarro N, Tonnuti E, et al. Detection o anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods. Recent Prog Med 1999;90:579-584.
45. Zampieri S, Ghirardello A, Doria A, et al. The use of tween 20 in immunoblotting assays for the detection of autoantibodies in connective tissue diseases. J Immunol Methods 2000;239:1-11.
46. Okano Y, Steen VD, Medsger TAJ. Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum 1992;35:95-100.